» Articles » PMID: 28455679

Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over

Overview
Journal Curr Obes Rep
Specialty Endocrinology
Date 2017 Apr 30
PMID 28455679
Citations 265
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: One begins to see improvement in glycemic measures and triglycerides with small amounts of weight loss, but with greater levels of weight loss there is even greater improvement. In fact, the relationship between weight loss and glycemia is one that is very close.

Recent Findings: This is fortunate for diabetes prevention; it takes only small amounts of weight loss to prevent progression to type 2 diabetes from impaired glucose tolerance, and after the 10 kg of weight loss, one cannot demonstrate much additional improvement in risk reduction. Modest weight loss (5 to 10%) is also associated with improvement in systolic and diastolic blood pressure and HDL cholesterol. With all these risk factors, more weight loss produces more improvement. Further, for patients with higher BMI levels (>40 kg/m), the ability to lose the same proportion of weight with lifestyle intervention is equal to that of those with lower BMI levels, and there is equal benefit in terms of risk factor improvement with modest weight loss. For some comorbid conditions, more weight loss is needed-10 to 15%-to translate into clinical improvement. This is true with obstructive sleep apnea and non-alcoholic steatotic hepatitis. There is a graded improvement in improvements in measures of quality of life, depression, mobility, sexual dysfunction, and urinary stress incontinence, whereby improvements are demonstrable with modest weight loss (5-10%) and with further weight loss there are further improvements. For polycystic ovarian syndrome and infertility, modest weight loss (beginning at 2-5%) can bring improvements in menstrual irregularities and fertility. Moderate weight loss (5-10%) has been shown to be associated with reduced health care costs. Reduction in mortality may take more than 10% weight loss, although definitive studies have not been done to demonstrate that weight loss per se is associated with mortality reduction. Clinicians in medical weight management should bear in mind that the target should be health improvement rather than a number on the scale. The individual patient's targeted health goal should be assessed for response rather than a prescribed percentage weight loss.

Citing Articles

Five-year follow-up of a randomized weight loss trial on a digital health behaviour change support system.

Turkkila E, Pekkala T, Merikallio H, Merikukka M, Heikkila L, Hukkanen J Int J Obes (Lond). 2025; .

PMID: 40089569 DOI: 10.1038/s41366-025-01742-4.


Demographic Factors Associated with Postoperative Complications in Primary Bariatric Surgery: A Rapid Review.

Hon J, Fahey P, Ariya M, Piya M, Craven A, Atlantis E Obes Surg. 2025; .

PMID: 40080280 DOI: 10.1007/s11695-025-07784-x.


Weight Management Strategies to Reduce Metabolic Morbidity in Women With Polycystic Ovary Syndrome.

Diakosavvas M, Oyebode O, Bhide P Curr Obes Rep. 2025; 14(1):22.

PMID: 40045077 PMC: 11882674. DOI: 10.1007/s13679-025-00614-2.


Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.


The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.

Eslam M, Fan J, Yu M, Wong V, Cua I, Liu C Hepatol Int. 2025; .

PMID: 40016576 DOI: 10.1007/s12072-024-10774-3.


References
1.
Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

2.
Hamman R, Wing R, Edelstein S, Lachin J, Bray G, Delahanty L . Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006; 29(9):2102-7. PMC: 1762038. DOI: 10.2337/dc06-0560. View

3.
Williamson D, Rejeski J, Lang W, Van Dorsten B, Fabricatore A, Toledo K . Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med. 2009; 169(2):163-71. PMC: 2705948. DOI: 10.1001/archinternmed.2008.544. View

4.
Ryan D, Heaner M . Guidelines (2013) for managing overweight and obesity in adults. Preface to the full report. Obesity (Silver Spring). 2014; 22 Suppl 2:S1-3. DOI: 10.1002/oby.20819. View

5.
Hunter D, Beavers D, Eckstein F, Guermazi A, Loeser R, Nicklas B . The Intensive Diet and Exercise for Arthritis (IDEA) trial: 18-month radiographic and MRI outcomes. Osteoarthritis Cartilage. 2015; 23(7):1090-8. PMC: 9178604. DOI: 10.1016/j.joca.2015.03.034. View